Benztropine Mesylate
- Product NDC
- 0615-7677
- 11-digit product format
- 006157677
- Labeler code
- 0615
- Product ID
- 0615-7677_a56bcb74-de50-4c37-9c79-dd33abe04687
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- benztropine mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA040103
- Marketing category
- ANDA
- Marketing start
- 1996-12-12
- Marketing end
- 0000-00-00
- Substance
- BENZTROPINE MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Anticholinergic [EPC],Antihistamine [EPC],Cholinergic Antagonists [MoA],Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 0615-7677 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 0615-7677 | 0615-7677-31 | D | Discontinued by firm | 2026-07-31 | |
| excluded package | package | 0615-7677 | 0615-7677-39 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040103-001 | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 1996-12-12 | |
| A040103-002 | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 1996-12-12 | |
| A040103-003 | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 1996-12-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040103-001 | AA |
| A040103-002 | AA |
| A040103-003 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040103-001 | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 1996-12-12 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040103-002 | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 1996-12-12 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A040103-003 | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 1996-12-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040103-001 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040103-002 | AA | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A040103-003 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Benztropine Mesylate | BENZTROPINE MESYLATE | Coupler LLC | 513b1f4c-d253-6ad7-e063-6394a90a1dab | 2026-05-07 | Warnings, Adverse reactions | 040103 ANDA040103 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | Coupler LLC | 50c61b1d-49d6-37f2-e063-6294a90a0590 | 2026-05-01 | Warnings, Adverse reactions | 040103 ANDA040103 |
| Benztropine Mesylate | BENZTROPINE MESYLATE | ScieGen Pharmaceuticals Inc | 1ead16a7-88ed-407d-b25a-0d9a1d9da5ef | 2026-01-09 | Warnings, Adverse reactions | 040103 ANDA040103 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7677-31 | 2021-03-17 | C162847 | 48780-1 | 9d75b9d0-3a36-f424-e053-dadaa90a57ce | BENZTROPINE MESYLATE TABLETS, USP |
| 0615-7677-39 | 2021-03-17 | C162847 | 48780-1 | 9d75b9d0-3a36-f424-e053-dadaa90a57ce | BENZTROPINE MESYLATE TABLETS, USP |
| 0615-7677-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3a36-f424-e053-dadaa90a57ce | BENZTROPINE MESYLATE TABLETS, USP |
| 0615-7677-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3a36-f424-e053-dadaa90a57ce | BENZTROPINE MESYLATE TABLETS, USP |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BENZTROPINE MESYLATE | ACTIVE INGREDIENT | WMJ8TL7510 | BENZTROPINE MESYLATE TABLET BENZTROPINE MESYLATE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 4 | |
| BENZTROPINE | ACTIVE MOIETY | 1NHL2J4X8K | BENZTROPINE MESYLATE TABLET BENZTROPINE MESYLATE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 4 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | BENZTROPINE MESYLATE TABLET BENZTROPINE MESYLATE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 4 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | BENZTROPINE MESYLATE TABLET BENZTROPINE MESYLATE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | BENZTROPINE MESYLATE TABLET BENZTROPINE MESYLATE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 4 | |
| POVIDONE K12 | INACTIVE INGREDIENT | 333AG72FWJ | BENZTROPINE MESYLATE TABLET BENZTROPINE MESYLATE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 4 |